USCA RIA’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $6.41M | Sell |
26,292
-9
| -0% | -$2.21K | 0.39% | 66 |
|
|
2021
Q1 | $6.54M | Buy |
26,301
+12,818
| +95% | +$3.06M | 0.43% | 61 |
|
|
2020
Q4 | $3.1M | Sell |
13,483
-41
| -0.3% | -$9.45K | 0.22% | 97 |
|
|
2020
Q3 | $3.44M | Buy |
13,524
+127
| +0.9% | +$31.5K | 0.27% | 85 |
|
|
2020
Q2 | $3.16M | Sell |
13,397
-347
| -3% | -$79.2K | 0.28% | 82 |
|
|
2020
Q1 | $2.79M | Buy |
13,744
+1,223
| +10% | +$267K | 0.32% | 76 |
|
|
2019
Q4 | $3.02M | Buy |
12,521
+1
| +0% | +$220 | 0.27% | 125 |
|
|
2019
Q3 | $2.42M | Sell |
12,520
-3,752
| -23% | -$720K | 0.24% | 124 |
|
|
2019
Q2 | $3M | Sell |
16,272
-6,066
| -27% | -$1.09M | 0.3% | 101 |
|
|
2019
Q1 | $4.24M | Buy |
22,338
+877
| +4% | +$167K | 0.46% | 65 |
|
|
2018
Q4 | $4.18M | Buy |
21,461
+4,401
| +26% | +$859K | 0.56% | 50 |
|
|
2018
Q3 | $3.54M | Sell |
17,060
-3,047
| -15% | -$600K | 0.36% | 82 |
|
|
2018
Q2 | $3.71M | Sell |
20,107
-8,927
| -31% | -$1.58M | 0.4% | 68 |
|
|
2018
Q1 | $4.95M | Sell |
29,034
-4,046
| -12% | -$743K | 0.55% | 44 |
|
|
2017
Q4 | $5.75M | Sell |
33,080
-3,343
| -9% | -$592K | 0.64% | 41 |
|
|
2017
Q3 | $6.27M | Hold |
36,423
| – | – | 0.81% | 27 |
|
|
2017
Q2 | $6.27M | Buy |
36,423
+23,837
| +189% | +$3.88M | 0.8% | 27 |
|
|
2017
Q1 | $2.06M | Sell |
12,586
-10,428
| -45% | -$1.73M | 0.3% | 105 |
|
|
2016
Q4 | $3.37M | Buy |
23,014
+18,077
| +366% | +$2.72M | 0.52% | 50 |
|
|
2016
Q3 | $824K | Sell |
4,937
-6,882
| -58% | -$1.16M | 0.14% | 179 |
|
|
2016
Q2 | $1.8M | Buy |
11,819
+272
| +2% | +$42.3K | 0.3% | 96 |
|
|
2016
Q1 | $1.73M | Buy |
11,547
+7,085
| +159% | +$1.05M | 0.31% | 86 |
|
|
2015
Q4 | $724K | Buy |
4,462
+503
| +13% | +$79.1K | 0.16% | 168 |
|
|
2015
Q3 | $548K | Buy |
3,959
+712
| +22% | +$112K | 0.14% | 172 |
|
|
2015
Q2 | $498K | Buy |
3,247
+221
| +7% | +$35.4K | 0.13% | 177 |
|
|
2015
Q1 | $484K | Buy |
3,026
+212
| +8% | +$33.4K | 0.13% | 182 |
|
|
2014
Q4 | $448K | Buy |
2,814
+302
| +12% | +$47.1K | 0.12% | 191 |
|
|
2014
Q3 | $353K | Buy |
2,512
+100
| +4% | +$13.1K | 0.11% | 212 |
|
|
2014
Q2 | $286K | Buy |
2,412
+200
| +9% | +$23.2K | 0.1% | 222 |
|
|
2014
Q1 | $273K | Sell |
2,212
-5,977
| -73% | -$725K | 0.1% | 216 |
|
|
2013
Q4 | $934K | Buy |
+8,189
| New | +$932K | 0.37% | 83 |
|
Other funds holding AMGN
USCA RIA's AMGN Position: Q2 2021 in Review
USCA RIA reduced its Amgen (AMGN) stake by 0.03% in Q2 2021, selling an estimated $2.21K and leaving 26,292 shares worth $6.41M. The position accounts for 0.39% of the portfolio, ranked #66.
USCA RIA first reported a position in AMGN in Q4 2013 and has held it in 31 quarters since. The position peaked at $6.54M in Q1 2021. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.
- USCA RIA held 26,292 shares of Amgen worth $6.41M as of Q2 2021.
- USCA RIA sold 9 Amgen shares in Q2 2021, an estimated $2.21K.
- Amgen made up 0.39% of USCA RIA's portfolio in Q2 2021, its #66 holding.
- USCA RIA first reported a position in Amgen in Q4 2013 and has held it in 31 quarters since.
- USCA RIA's Amgen position peaked at $6.54M in Q1 2021.
- 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.
Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.